Morgens Waterfall Vintiadis & Co’s AstraZeneca AZN Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,500	Closed	-$2.44M	–	33
2021 Q1	$2.44M	Sell	24,500 -2,500	-9%	-$251K	1.35%	27
2020 Q4	$2.7M	Hold	27,000	–	–	1.46%	23
2020 Q3	$2.96M	Hold	27,000	–	–	1.69%	24
2020 Q2	$2.86M	Buy	27,000 +21,400	+382%	+$2.21M	1.84%	25
2020 Q1	$500K	Sell	5,600 -850	-13%	-$80K	0.47%	29
2019 Q4	$643K	Hold	6,450	–	–	0.44%	39
2019 Q3	$575K	Hold	6,450	–	–	0.44%	40
2019 Q2	$533K	Hold	6,450	–	–	0.37%	41
2019 Q1	$522K	Hold	6,450	–	–	0.37%	50
2018 Q4	$490K	Buy	6,450 +350	+6%	+$27.3K	0.44%	47
2018 Q3	$483K	Hold	6,100	–	–	0.32%	52
2018 Q2	$428K	Hold	6,100	–	–	0.3%	54
2018 Q1	$427K	Buy	+6,100	New	+$423K	0.32%	54

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's AZN Position: Q2 2021 in Review

Morgens Waterfall Vintiadis & Co sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 24,500 shares — an estimated $2.44M sold.

Morgens Waterfall Vintiadis & Co first reported a position in AZN in Q1 2018 and held it in 13 quarters. The position peaked at $2.96M in Q3 2020. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

Morgens Waterfall Vintiadis & Co reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
Morgens Waterfall Vintiadis & Co sold 24,500 AstraZeneca shares in Q2 2021, an estimated $2.44M.
Morgens Waterfall Vintiadis & Co first reported a position in AstraZeneca in Q1 2018 and held it in 13 quarters.
Morgens Waterfall Vintiadis & Co's AstraZeneca position peaked at $2.96M in Q3 2020.
771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2021, filed 16 Aug 2021.